Surgery at primary versus relapsed epithelial ovarian cancer: a study on aspects of anaesthesiological management.

Background: Primary cytoreductive surgery (CS) for epithelial ovarian cancer (EOC) is well-established. CS at relapse remains controversial, with an unclear morbidity profile.

Patients And Methods: We analyzed 121 patients with EOC who underwent CS.

Impact of ascites on the perioperative course of patients with advanced ovarian cancer undergoing extensive cytoreduction: results of a study on 119 patients.

Objective: Cytoreductive surgery for epithelial ovarian cancer (EOC) is the cornerstone of multimodal therapy and considered as a high-risk surgery because of extensive multivisceral procedures. In most patients, ascites is present, but its impact on the surgical and clinical outcomes is unclear.

Methods: One hundred nineteen patients undergoing surgical cytoreduction because of EOC between 2005 and 2008 were included.